SCHEMBL6792786

SCHEMBL6792786

Cc1ccc(-c2ccccc2C(=O)Nc2ccc(N(CCc3cscn3)C(=O)O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 2/20 0.39
LMNA P02545 3/20 0.39
AGTR1 P30556 1/20 0.39
AGTR2 P50052 1/20 0.39
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6501858 0.92 GCGR (0.43) KMT2AALDH1A1NPC1RAB9APOLB
SCHEMBL6792292 0.91 ALDH1A1 (0.41) ALDH1A1LTB4R2NPC1RAB9ACHRNB2
SCHEMBL6491092 0.91 CYP3A4 (0.38) KMT2AALDH1A1NPC1RAB9APOLB
SCHEMBL6796239 0.91 GAA (0.55) KMT2AALDH1A1LTB4R2NPC1RAB9A
SCHEMBL6503623 0.88 MTTP (0.40) NPC1RAB9AKDM4ECYP3A4CASP3
SCHEMBL6498587 0.84 APOB (0.44) NPC1RAB9AKDM4ECYP3A4LMNA
SCHEMBL6788446 0.83 KMT2A (0.46) KMT2AALDH1A1NPC1RAB9ACHRNB2
SCHEMBL6793528 0.81 NR3C1 (0.41) KMT2AALDH1A1LTB4R2NPC1CHRNB2
SCHEMBL6794600 0.81 L3MBTL1 (0.44) KMT2AALDH1A1NPC1RAB9ACHRNB2
SCHEMBL6794499 0.80 CYP3A4 (0.40) KMT2AALDH1A1LTB4R2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 KMT2A 2457/4885ALDH1A1 1427/4885LTB4R2 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.